A survey on artificial intelligence approaches in supporting frontline workers and decision makers for the COVID-19 pandemic

Stratifying risk of disease in haematuria patients using machine learning techniques to improve diagnostics

Background

Detailed and invasive clinical investigations are required to identify the causes of haematuria. Highly unbalanced patient population (predominantly male) and a wide range of potential causes make the ability to correctly classify patients and identify patient-specific biomarkers a major challenge. Studies have shown that it is possible to improve the diagnosis using multi-marker analysis, even in unbalanced datasets, by applying advanced analytical methods. Here, we applied several machine learning algorithms to classify patients from the haematuria patient cohort (HaBio) by analysing multiple biomarkers and to identify the most relevant ones.

Materials and methods

We applied several classification and feature selection methods (k-means clustering, decision trees, random forest with LIME explainer and CACTUS algorithm) to stratify patients into two groups: healthy (with no clear cause of haematuria) or sick (with an identified cause of haematuria e.g., bladder cancer, or infection). The classification performance of the models was compared. Biomarkers identified as important by the algorithms were also analysed in relation to their involvement in the pathological processes.

Results

Results showed that a high unbalance in the datasets significantly affected the classification by random forest and decision trees, leading to the overestimation of the sick class and low model performance. CACTUS algorithm was more robust to the unbalance in the dataset. CACTUS obtained a balanced accuracy of 0.747 for both genders, 0.718 for females and 0.803 for males. The analysis showed that in the classification process for the whole dataset: microalbumin, male gender, and tPSA emerged as the most informative biomarkers. For males: age, microalbumin, tPSA, cystatin C, BTA, HAD and S100A4 were the most significant biomarkers while for females microalbumin, IL-8, pERK, and CXCL16.

Conclusions

CACTUS algorithm demonstrated improved performance compared with other methods such as decision trees and random forest. Additionally, we identified the most relevant biomarkers for the specific patient group, which could be considered in the future as novel biomarkers for diagnosis. Our results have the potential to inform future research and provide new personalised diagnostic approaches tailored directly to the needs of the individuals.

Innovative applications of artificial intelligence during the COVID-19 pandemic

The COVID-19 pandemic has created unprecedented challenges worldwide. Artificial intelligence (AI) technologies hold tremendous potential for tackling key aspects of pandemic management and response. In the present review, we discuss the tremendous possibilities of AI technology in addressing the global challenges posed by the COVID-19 pandemic. First, we outline the multiple impacts of the current pandemic on public health, the economy, and society. Next, we focus on the innovative applications of advanced AI technologies in key areas such as COVID-19 prediction, detection, control, and drug discovery for treatment. Specifically, AI-based predictive analytics models can use clinical, epidemiological, and omics data to forecast disease spread and patient outcomes. Additionally, deep neural networks enable rapid diagnosis through medical imaging. Intelligent systems can support risk assessment, decision-making, and social sensing, thereby improving epidemic control and public health policies. Furthermore, high-throughput virtual screening enables AI to accelerate the identification of therapeutic drug candidates and opportunities for drug repurposing. Finally, we discuss future research directions for AI technology in combating COVID-19, emphasizing the importance of interdisciplinary collaboration. Though promising, barriers related to model generalization, data quality, infrastructure readiness, and ethical risks must be addressed to fully translate these innovations into real-world impacts. Multidisciplinary collaboration engaging diverse expertise and stakeholders is imperative for developing robust, responsible, and human-centered AI solutions against COVID-19 and future public health emergencies.

Agent-based social simulations for health crises response: utilising the everyday digital health perspective

There is increasing recognition of the role that artificial intelligence (AI) systems can play in managing health crises. One such approach, which allows for analysing the potential consequences of different policy interventions is agent-based social simulations (ABSS). Here, the actions and interactions of autonomous agents are modelled to generate virtual societies that can serve as a "testbed" for investigating and comparing different interventions and scenarios. This piece focuses on two key challenges of ABSS in collaborative policy interventions during the COVID-19 pandemic. These were defining valuable scenarios to simulate and the availability of appropriate data. This paper posits that drawing on the research on the "everyday" digital health perspective in designing ABSS before or during health crises, can overcome aspects of these challenges. The focus on digital health interventions reflects a rapid shift in the adoption of such technologies during and after the COVID-19 pandemic, and the new challenges this poses for policy makers. It is argued that by accounting for the everyday digital health in modelling, ABSS would be a more powerful tool in future health crisis management.

Artificial intelligence applied to analyzes during the pandemic: COVID-19 beds occupancy in the state of Rio Grande do Norte, Brazil

The COVID-19 pandemic is already considered one of the biggest global health crises. In Rio Grande do Norte, a Brazilian state, the RegulaRN platform was the health information system used to regulate beds for patients with COVID-19. This article explored machine learning and deep learning techniques with RegulaRN data in order to identify the best models and parameters to predict the outcome of a hospitalized patient. A total of 25,366 bed regulations for COVID-19 patients were analyzed. The data analyzed comes from the RegulaRN Platform database from April 2020 to August 2022. From these data, the nine most pertinent characteristics were selected from the twenty available, and blank or inconclusive data were excluded. This was followed by the following steps: data pre-processing, database balancing, training, and test. The results showed better performance in terms of accuracy (84.01%), precision (79.57%), and F1-score (81.00%) for the Multilayer Perceptron model with Stochastic Gradient Descent optimizer. The best results for recall (84.67%), specificity (84.67%), and ROC-AUC (91.6%) were achieved by Root Mean Squared Propagation. This study compared different computational methods of machine and deep learning whose objective was to classify bed regulation data for patients with COVID-19 from the RegulaRN Platform. The results have made it possible to identify the best model to help health professionals during the process of regulating beds for patients with COVID-19. The scientific findings of this article demonstrate that the computational methods used applied through a digital health solution, can assist in the decision-making of medical regulators and government institutions in situations of public health crisis.

Needs and expectations for artificial intelligence in emergency medicine according to Canadian physicians

BACKGROUND

Artificial Intelligence (AI) is recognized by emergency physicians (EPs) as an important technology that will affect clinical practice. Several AI-tools have already been developed to aid care delivery in emergency medicine (EM). However, many EM tools appear to have been developed without a cross-disciplinary needs assessment, making it difficult to understand their broader importance to general-practice. Clinician surveys about AI tools have been conducted within other medical specialties to help guide future design. This study aims to understand the needs of Canadian EPs for the apt use of AI-based tools.

METHODS

A national cross-sectional, two-stage, mixed-method electronic survey of Canadian EPs was conducted from January-May 2022. The survey includes demographic and physician practice-pattern data, clinicians' current use and perceptions of AI, and individual rankings of which EM work-activities most benefit from AI.

RESULTS

The primary outcome is a ranked list of high-priority AI-tools for EM that physicians want translated into general use within the next 10 years. When ranking specific AI examples, 'automated charting/report generation', 'clinical prediction rules' and 'monitoring vitals with early-warning detection' were the top items. When ranking by physician work-activities, 'AI-tools for documentation', 'AI-tools for computer use' and 'AI-tools for triaging patients' were the top items. For secondary outcomes, EPs indicated AI was 'likely' (43.1%) or 'extremely likely' (43.7%) to be able to complete the task of 'documentation' and indicated either 'a-great-deal' (32.8%) or 'quite-a-bit' (39.7%) of potential for AI in EM. Further, EPs were either 'strongly' (48.5%) or 'somewhat' (39.8%) interested in AI for EM.

CONCLUSIONS

Physician input on the design of AI is essential to ensure the uptake of this technology. Translation of AI-tools to facilitate documentation is considered a high-priority, and respondents had high confidence that AI could facilitate this task. This study will guide future directions regarding the use of AI for EM and help direct efforts to address prevailing technology-translation barriers such as access to high-quality application-specific data and developing reporting guidelines for specific AI-applications. With a prioritized list of high-need AI applications, decision-makers can develop focused strategies to address these larger obstacles.

A new parallel multi-objective Harris hawk algorithm for predicting the mortality of COVID-19 patients

Harris' Hawk Optimization (HHO) is a novel metaheuristic inspired by the collective hunting behaviors of hawks. This technique employs the flight patterns of hawks to produce (near)-optimal solutions, enhanced with feature selection, for challenging classification problems. In this study, we propose a new parallel multi-objective HHO algorithm for predicting the mortality risk of COVID-19 patients based on their symptoms. There are two objectives in this optimization problem: to reduce the number of features while increasing the accuracy of the predictions. We conduct comprehensive experiments on a recent real-world COVID-19 dataset from Kaggle. An augmented version of the COVID-19 dataset is also generated and experimentally shown to improve the quality of the solutions. Significant improvements are observed compared to existing state-of-the-art metaheuristic wrapper algorithms. We report better classification results with feature selection than when using the entire set of features. During experiments, a 98.15% prediction accuracy with a 45% reduction is achieved in the number of features. We successfully obtained new best solutions for this COVID-19 dataset.

Group early intervention eye movement desensitization and reprocessing therapy as a video-conference psychotherapy with frontline/emergency workers in response to the COVID-19 pandemic in the treatment of post-traumatic stress disorder and moral injury-An RCT study

Objective

Frontline mental health, emergency, law enforcement, and social workers have faced unprecedented psychological distress in responding to the COVID-19 pandemic. The purpose of the RCT (Randomized Controls Trial) study was to investigate the effectiveness of a Group EMDR (Eye Movement Desensitization and Reprocessing) therapy (Group Traumatic Episode Protocol-GTEP) in the treatment of Post-Traumatic Stress Disorder (PTSD) and Moral Injury. The treatment focus is an early intervention, group trauma treatment, delivered remotely as video-conference psychotherapy (VCP). This early intervention used an intensive treatment delivery of 4x2h sessions over 1-week. Additionally, the group EMDR intervention utilized therapist rotation in treatment delivery.

Methods

The study's design comprised a delayed (1-month) treatment intervention (control) versus an active group. Measurements included the International Trauma Questionnaire (ITQ), Generalized Anxiety Disorder Assessment (GAD-7), Patient Health Questionnaire (PHQ-9), Moral Injury Events Scale (MIES), and a Quality-of-Life psychometric (EQ-5D), tested at T0, T1: pre-treatment, T2: post-treatment, T3: 1-month follow-up (FU), T4: 3-month FU, and T5: 6-month FU. The Adverse Childhood Experiences - International version (ACEs), Benevolent Childhood Experience (BCEs) was ascertained at pre-treatment only. N = 85 completed the study.

Results

Results highlight a significant treatment effect within both active and control groups. Post Hoc comparisons of the ITQ demonstrated a significant difference between T1 pre (mean 36.8, SD 14.8) and T2 post (21.2, 15.1) (t11.58) = 15.68, p < 0.001). Further changes were also seen related to co-morbid factors. Post Hoc comparisons of the GAD-7 demonstrated significant difference between T1 pre (11.2, 4.91) and T2 post (6.49, 4.73) (t = 6.22) = 4.41, p < 0.001; with significant difference also with the PHQ-9 between T1 pre (11.7, 5.68) and T2 post (6.64, 5.79) (t = 6.30) = 3.95, p < 0.001, d = 0.71. The treatment effect occurred irrespective of either ACEs/BCEs during childhood. However, regarding Moral Injury, the MIES demonstrated no treatment effect between T1 pre and T5 6-month FU. The study's findings discuss the impact of Group EMDR therapy delivered remotely as video-conference psychotherapy (VCP) and the benefits of including a therapist/rotation model as a means of treatment delivery. However, despite promising results suggesting a large treatment effect in the treatment of trauma and adverse memories, including co-morbid symptoms, research results yielded no treatment effect in frontline/emergency workers in addressing moral injury related to the COVID-19 pandemic.

Conclusion

The NICE (2018) guidance on PTSD highlighted the paucity of EMDR therapy research used as an early intervention. The primary rationale for this study was to address this critical issue. In summary, treatment results for group EMDR, delivered virtually, intensively, using therapist rotation are tentatively promising, however, the moral dimensions of trauma need consideration for future research, intervention development, and potential for further scalability. The data contributes to the emerging literature on early trauma interventions.Clinical Trial Registration:Clinicaltrials.gov, ISRCTN16933691.

Strategies to Improve the Impact of Artificial Intelligence on Health Equity: Scoping Review

BACKGROUND

Emerging artificial intelligence (AI) applications have the potential to improve health, but they may also perpetuate or exacerbate inequities.

OBJECTIVE

This review aims to provide a comprehensive overview of the health equity issues related to the use of AI applications and identify strategies proposed to address them.

METHODS

We searched PubMed, Web of Science, the IEEE (Institute of Electrical and Electronics Engineers) Xplore Digital Library, ProQuest U.S. Newsstream, Academic Search Complete, the Food and Drug Administration (FDA) website, and ClinicalTrials.gov to identify academic and gray literature related to AI and health equity that were published between 2014 and 2021 and additional literature related to AI and health equity during the COVID-19 pandemic from 2020 and 2021. Literature was eligible for inclusion in our review if it identified at least one equity issue and a corresponding strategy to address it. To organize and synthesize equity issues, we adopted a 4-step AI application framework: Background Context, Data Characteristics, Model Design, and Deployment. We then created a many-to-many mapping of the links between issues and strategies.

RESULTS

In 660 documents, we identified 18 equity issues and 15 strategies to address them. Equity issues related to Data Characteristics and Model Design were the most common. The most common strategies recommended to improve equity were improving the quantity and quality of data, evaluating the disparities introduced by an application, increasing model reporting and transparency, involving the broader community in AI application development, and improving governance.

CONCLUSIONS

Stakeholders should review our many-to-many mapping of equity issues and strategies when planning, developing, and implementing AI applications in health care so that they can make appropriate plans to ensure equity for populations affected by their products. AI application developers should consider adopting equity-focused checklists, and regulators such as the FDA should consider requiring them. Given that our review was limited to documents published online, developers may have unpublished knowledge of additional issues and strategies that we were unable to identify.

Systematic review of MCDM approach applied to the medical case studies of COVID-19: trends, bibliographic analysis, challenges, motivations, recommendations, and future directions

When COVID-19 spread in China in December 2019, thousands of studies have focused on this pandemic. Each presents a unique perspective that reflects the pandemic's main scientific disciplines. For example, social scientists are concerned with reducing the psychological impact on the human mental state especially during lockdown periods. Computer scientists focus on establishing fast and accurate computerized tools to assist in diagnosing, preventing, and recovering from the disease. Medical scientists and doctors, or the frontliners, are the main heroes who received, treated, and worked with the millions of cases at the expense of their own health. Some of them have continued to work even at the expense of their lives. All these studies enforce the multidisciplinary work where scientists from different academic disciplines (social, environmental, technological, etc.) join forces to produce research for beneficial outcomes during the crisis. One of the many branches is computer science along with its various technologies, including artificial intelligence, Internet of Things, big data, decision support systems (DSS), and many more. Among the most notable DSS utilization is those related to multicriterion decision making (MCDM), which is applied in various applications and across many contexts, including business, social, technological and medical. Owing to its importance in developing proper decision regimens and prevention strategies with precise judgment, it is deemed a noteworthy topic of extensive exploration, especially in the context of COVID-19-related medical applications. The present study is a comprehensive review of COVID-19-related medical case studies with MCDM using a systematic review protocol. PRISMA methodology is utilized to obtain a final set of (n = 35) articles from four major scientific databases (ScienceDirect, IEEE Xplore, Scopus, and Web of Science). The final set of articles is categorized into taxonomy comprising five groups: (1) diagnosis (n = 6), (2) safety (n = 11), (3) hospital (n = 8), (4) treatment (n = 4), and (5) review (n = 3). A bibliographic analysis is also presented on the basis of annual scientific production, country scientific production, co-occurrence, and co-authorship. A comprehensive discussion is also presented to discuss the main challenges, motivations, and recommendations in using MCDM research in COVID-19-related medial case studies. Lastly, we identify critical research gaps with their corresponding solutions and detailed methodologies to serve as a guide for future directions. In conclusion, MCDM can be utilized in the medical field effectively to optimize the resources and make the best choices particularly during pandemics and natural disasters.

An intelligent deep convolutional network based COVID-19 detection from chest X-rays

Coronavirus disease-2019 (COVID-19) seems to be a fast spreading contagious illness that affects both humans and animals. This catastrophic deadly virus has an impact on people's daily lives, their wellbeing, and a nation's economy. According to a clinical research of COVID-19 affected patients, these individuals have been most commonly infected with a lung illness after coming into touch with the virus. A chest X-ray (also known as radiography) or a chest CT scan seems to be more efficient imaging techniques for detecting lung issues. Nonetheless, when compared to a chest CT, a significant chest X-ray remains a less expensive procedure. Thus, in this research, a novel Deep convolution neural network algorithm is presented to detect the COVID-19 from X-ray image. Moreover, to enhance diagnostics sensitivity and reduce error rate, a hybrid Two-step-AS clustering approach with Ensemble Bootstrap aggregating training and Multiple NN methods used. In addition, TSEBANN model has been employed to explore the qualification procedure effects. The proposed algorithm was trained before and after classification while compared to traditional Convolutional Neural Network (CNN). After, the process of pre-processing and feature extraction, the CNN strategy was adopted as an identification approach to categorize the information depending on Chest X-ray recognition. These examples were then classified using the CNN classification technique. The testing was conducted on the COVID-19 X-ray dataset, and the cross-validation approach was used to determine the model’s validity. The result indicated that a CNN system classification has attained an accuracy of 98.062 %.

Chest X-ray analysis empowered with deep learning: A systematic review

Chest radiographs are widely used in the medical domain and at present, chest X-radiation particularly plays an important role in the diagnosis of medical conditions such as pneumonia and COVID-19 disease. The recent developments of deep learning techniques led to a promising performance in medical image classification and prediction tasks. With the availability of chest X-ray datasets and emerging trends in data engineering techniques, there is a growth in recent related publications. Recently, there have been only a few survey papers that addressed chest X-ray classification using deep learning techniques. However, they lack the analysis of the trends of recent studies. This systematic review paper explores and provides a comprehensive analysis of the related studies that have used deep learning techniques to analyze chest X-ray images. We present the state-of-the-art deep learning based pneumonia and COVID-19 detection solutions, trends in recent studies, publicly available datasets, guidance to follow a deep learning process, challenges and potential future research directions in this domain. The discoveries and the conclusions of the reviewed work have been organized in a way that researchers and developers working in the same domain can use this work to support them in taking decisions on their research.

Federated learning-based AI approaches in smart healthcare: concepts, taxonomies, challenges and open issues

Federated Learning (FL), Artificial Intelligence (AI), and Explainable Artificial Intelligence (XAI) are the most trending and exciting technology in the intelligent healthcare field. Traditionally, the healthcare system works based on centralized agents sharing their raw data. Therefore, huge vulnerabilities and challenges are still existing in this system. However, integrating with AI, the system would be multiple agent collaborators who are capable of communicating with their desired host efficiently. Again, FL is another interesting feature, which works decentralized manner; it maintains the communication based on a model in the preferred system without transferring the raw data. The combination of FL, AI, and XAI techniques can be capable of minimizing several limitations and challenges in the healthcare system. This paper presents a complete analysis of FL using AI for smart healthcare applications. Initially, we discuss contemporary concepts of emerging technologies such as FL, AI, XAI, and the healthcare system. We integrate and classify the FL-AI with healthcare technologies in different domains. Further, we address the existing problems, including security, privacy, stability, and reliability in the healthcare field. In addition, we guide the readers to solving strategies of healthcare using FL and AI. Finally, we address extensive research areas as well as future potential prospects regarding FL-based AI research in the healthcare management system.

An Intelligent Gender Classification System in the Era of Pandemic Chaos with Veiled Faces

In the world of chaos, the pandemic has driven individuals around the globe to wear face masks for preventing the virus’s transmission, however, this has made it difficult to determine the gender of the person wearing a mask. Gender information is part of soft biometrics, which provides extra information about a person’s identification, thus, identifying a gender based on a veiled face is among the urgent challenges that must be advocated for in the next decade. Therefore, this study exploited various pre-trained deep learning networks (DenseNet121, DenseNet169, ResNet50, ResNet101, Xception, InceptionV3, MobileNetV2, EfficientNetB0, and VGG16) to analyze the effect of the mask while identifying the gender using facial images of human beings. The study comprises two strategies. First, the experimental part involves the training of models using facial images with and without masks, while the second strategy considers images with masks only, to train the pre-trained models. Experimental results reveal that DenseNet121 and Xception networks performed well for both strategies. Besides this, the Inception network outperformed all others by attaining 98.75% accuracy for the first strategy, whereas EfficientNetB0 performed well for the second strategy by securing 97.27%. Moreover, results suggest that facemasks evidently impact the performance of state-of-the-art pre-trained networks for gender classification.

Screening Lung Diseases Using Cascaded Feature Generation and Selection Strategies

The global pandemic COVID-19 is still a cause of a health emergency in several parts of the world. Apart from standard testing techniques to identify positive cases, auxiliary tools based on artificial intelligence can help with the identification and containment of the disease. The need for the development of alternative smart diagnostic tools to combat the COVID-19 pandemic has become more urgent. In this study, a smart auxiliary framework based on machine learning (ML) is proposed; it can help medical practitioners in the identification of COVID-19-affected patients, among others with pneumonia and healthy individuals, and can help in monitoring the status of COVID-19 cases using X-ray images. We investigated the application of transfer-learning (TL) networks and various feature-selection techniques for improving the classification accuracy of ML classifiers. Three different TL networks were tested to generate relevant features from images; these TL networks include AlexNet, ResNet101, and SqueezeNet. The generated relevant features were further refined by applying feature-selection methods that include iterative neighborhood component analysis (iNCA), iterative chi-square (iChi2), and iterative maximum relevance–minimum redundancy (iMRMR). Finally, classification was performed using convolutional neural network (CNN), linear discriminant analysis (LDA), and support vector machine (SVM) classifiers. Moreover, the study exploited stationary wavelet (SW) transform to handle the overfitting problem by decomposing each image in the training set up to three levels. Furthermore, it enhanced the dataset, using various operations as data-augmentation techniques, including random rotation, translation, and shear operations. The analysis revealed that the combination of AlexNet, ResNet101, SqueezeNet, iChi2, and SVM was very effective in the classification of X-ray images, producing a classification accuracy of 99.2%. Similarly, AlexNet, ResNet101, and SqueezeNet, along with iChi2 and the proposed CNN network, yielded 99.0% accuracy. The results showed that the cascaded feature generator and selection strategies significantly affected the performance accuracy of the classifier.

The Role of Digital Technology in Curbing COVID-19

Introduction: Using digital technology to provide support, medical consultations, healthcare services, and to track the spread of the coronavirus has been identified as an important solution to curb the transmission of the virus. This research paper aims to (1) summarize the digital technologies used during the COVID-19 pandemic to mitigate the transmission of the COVID-19; (2) establish the extent to which digital technology applications have facilitated mitigation of the spread of COVID-19; and (3) explore the facilitators and barriers that impact the usability of digital technologies throughout the pandemic. Methods: A rapid electronic search following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted of available records up to June 2022 on the medical databases PubMed, Ovid, Embase, CINHAIL, the Cochrane Library, Web of Science, and Google Scholar. Results: An increasing number and variety of digital health applications have been available throughout the pandemic, such as telehealth, smartphone mobile health apps, machine learning, and artificial intelligence. Each technology has played a particular role in curbing COVID-19 transmission. Different users have gained benefits from using digital technology during the COVID-19 pandemic and different determinants have contributed to accelerating the wheel of digital technology implementation during the pandemic. Conclusion: Digital health during the COVID-19 pandemic has evolved very rapidly, with different applications and roles aimed at curbing the pandemic.

Analyzing the Effect of Filtering and Feature-Extraction Techniques in a Machine Learning Model for Identification of Infectious Disease Using Radiography Imaging

The massive adaptation of reverse transcriptase-polymerase chain reaction (RT-PCR) has facilitated efforts to battle against the COVID-19 pandemic that has inflicted millions of individuals around the world. Besides RT-PCR, radiography imaging examinations yields valuable insight for detecting and diagnosing this infectious disease. Thus, this paper proposed a computer vision and artificial-intelligence-based hybrid approach aid in efficient detection and control of COVID-19 disease. The study utilized chest X-ray images to segregate COVID-19 positive cases among healthy individuals by exploiting several combinational structures of image filtering, feature-extraction techniques, and machine learning algorithms. It analyzed the effects of three noise removal filters and two feature-extraction techniques on performance of several machine learning and deep-learning-based classifiers. The proposed schemes first remove unnecessary noise using a conservative smoothing filter, Crimmins speckle removal, and Gaussian filter. It then employs linear discriminant analysis (LDA) as linear method and principal component analysis (PCA) as non-linear feature-extraction technique to extract highly discriminant feature sets. Finally, it uses these feature sets to train various classification models, including convolutional neural network (CNN), support vector machine (SVM), and logistic regression (LG). Evidently, the proposed conservative smoothing filter with single peak to maintain symmetry in horizontal and vertical directions for enhancement of image, along with LDA and SVM, secured an overall classification accuracy of 99.93%. Experimental results show that, besides achieving high accuracies, the incorporation of feature-extraction techniques significantly reduces the computational time of the proposed model.

When might host heterogeneity drive the evolution of asymptomatic, pandemic coronaviruses?

Controlling many infectious diseases, including SARS-Coronavirus-2 (SARS-CoV-2), requires surveillance followed by isolation, contact-tracing and quarantining. These interventions often begin by identifying symptomatic individuals. However, actively removing pathogen strains causing symptomatic infections may inadvertently select for strains less likely to cause symptomatic infections. Moreover, a pathogen's fitness landscape is structured around a heterogeneous host pool; uneven surveillance efforts and distinct transmission risks across host classes can meaningfully alter selection pressures. Here, we explore this interplay between evolution caused by disease control efforts and the evolutionary consequences of host heterogeneity. Using an evolutionary epidemiology model parameterized for coronaviruses, we show that intense symptoms-driven disease control selects for asymptomatic strains, particularly when these efforts are applied unevenly across host groups. Under these conditions, increasing quarantine efforts have diverging effects. If isolation alone cannot eradicate, intensive quarantine efforts combined with uneven detections of asymptomatic infections (e.g., via neglect of some host classes) can favor the evolution of asymptomatic strains. We further show how, when intervention intensity depends on the prevalence of symptomatic infections, higher removal efforts (and isolating symptomatic cases in particular) more readily select for asymptomatic strains than when these efforts do not depend on prevalence. The selection pressures on pathogens caused by isolation and quarantining likely lie between the extremes of no intervention and thoroughly successful eradication. Thus, analyzing how different public health responses can select for asymptomatic pathogen strains is critical for identifying disease suppression efforts that can effectively manage emerging infectious diseases.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11071-022-07548-7.

Machine Learning-Based Research for COVID-19 Detection, Diagnosis, and Prediction: A Survey

The year 2020 experienced an unprecedented pandemic called COVID-19, which impacted the whole world. The absence of treatment has motivated research in all fields to deal with it. In Computer Science, contributions mainly include the development of methods for the diagnosis, detection, and prediction of COVID-19 cases. Data science and Machine Learning (ML) are the most widely used techniques in this area. This paper presents an overview of more than 160 ML-based approaches developed to combat COVID-19. They come from various sources like Elsevier, Springer, ArXiv, MedRxiv, and IEEE Xplore. They are analyzed and classified into two categories: Supervised Learning-based approaches and Deep Learning-based ones. In each category, the employed ML algorithm is specified and a number of used parameters is given. The parameters set for each of the algorithms are gathered in different tables. They include the type of the addressed problem (detection, diagnosis, or detection), the type of the analyzed data (Text data, X-ray images, CT images, Time series, Clinical data,...) and the evaluated metrics (accuracy, precision, sensitivity, specificity, F1-Score, and AUC). The study discusses the collected information and provides a number of statistics drawing a picture about the state of the art. Results show that Deep Learning is used in 79% of cases where 65% of them are based on the Convolutional Neural Network (CNN) and 17% use Specialized CNN. On his side, supervised learning is found in only 16% of the reviewed approaches and only Random Forest, Support Vector Machine (SVM) and Regression algorithms are employed.

Automatic diagnosis of COVID-19 disease using deep convolutional neural network with multi-feature channel from respiratory sound data: Cough, voice, and breath

The problem of respiratory sound classification has received good attention from the clinical scientists and medical researcher’s community in the last year to the diagnosis of COVID-19 disease. The Artificial Intelligence (AI) based models deployed into the real-world to identify the COVID-19 disease from human-generated sounds such as voice/speech, dry cough, and breath. The CNN (Convolutional Neural Network) is used to solve many real-world problems with Artificial Intelligence (AI) based machines. We have proposed and implemented a multi-channeled Deep Convolutional Neural Network (DCNN) for automatic diagnosis of COVID-19 disease from human respiratory sounds like a voice, dry cough, and breath, and it will give better accuracy and performance than previous models. We have applied multi-feature channels such as the data De-noising Auto Encoder (DAE) technique, GFCC (Gamma-tone Frequency Cepstral Coefficients), and IMFCC (Improved Multi-frequency Cepstral Coefficients) methods on augmented data to extract the deep features for the input of the CNN. The proposed approach improves system performance to the diagnosis of COVID-19 disease and provides better results on the COVID-19 respiratory sound dataset.

CR19: a framework for preliminary detection of COVID-19 in cough audio signals using machine learning algorithms for automated medical diagnosis applications

Today, there is a level of panic and chaos dominating the entire world due to the massive outbreak in the second wave of COVID-19 disease. As the disease has numerous symptoms ranging from a simple fever to the inability to breathe, which may lead to death. One of these symptoms is a cough which is considered one of the most common symptoms for COVID-19 disease. Recent research shows that the cough of a COVID-19 patient has distinct features that are different from other diseases. Consequently, the cough sound can be detected and classified to be used as a preliminary diagnosis of the COVID-19, which will help in reducing the spreading of that disease. The artificial intelligence (AI) engine can diagnose COVID-19 diseases by executing differential analysis of its inherent characteristics and comparing it to other non-COVID-19 coughs. However, the diagnosis of a COVID-19 infection by cough alone is an extremely challenging multidisciplinary problem. Therefore, this paper proposes a hybrid framework for efficiently COVID-19 detection and diagnosis using various ML algorithms from cough audio signals. The accuracy of this framework is improved with the utilization of the genetic algorithm with the ML techniques. We also assess the proposed system called CR19 for diagnosis on metrics such as precision, recall, F-measure. The results proved that the hybrid (GA-ML) technique provides superior results based on different evaluation metrics compared with ML approaches such as LR, LDA, KNN, CART, NB, and SVM. The proposed framework achieve an accuracy equal to 92.19%, 94.32%, 97.87%, 92.19%, 91.48%, and 93.61% in compared with the ML are 90.78, 92.90, 95.74, 87.94, 81.56, and 92.198 for LR, LDA, KNN, CART, NB, and SVM respectively. The proposed framework will efficiently help the physicians provide a proper medical decision regarding the COVID-19 analysis, thereby saving more lives. Therefore, this CR19 framework can be a clinical decision assistance tool used to channel clinical testing and treatment to those who need it the most, thereby saving more lives.

Quantum Edge Extraction of Chest CT Image for the Detection and Differentiation of Infected Region of COVID-19 Patient

The COVID-19 outbreak requires urgent public health attention throughout the world due to having its fast human to human transmission. As per the guidelines of the World Health Organization, rapid testing, vaccination, and isolation are the only options to break the chain of COVID-19 infection. Lung computed tomography (CT) plays a prime role in the accurate detection of COVID-19. For detection and pattern analysis of COVID-19, here an improved Sobel quantum edge extraction with non-maximum suppression and adaptive threshold (ISQEENSAT) has been employed to extract clinical information of infected lungs suppressing minimal noises present in the chest. In comparison with conventional classical edge extraction operators, the proposed technique can detect more sharp and accurate clinical edges of peripheral ground-glass opacity that appeared in the initial stage of COVID-19 patients. The edge extraction results assure the detection and differentiation of COVID-19 infection. ISQEENSAT can be a useful tool for assisting COVID-19 analysis and can help the physician to detect the region how much it has infected.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13369-021-06511-9.

COVID-19 disease diagnosis with light-weight CNN using modified MFCC and enhanced GFCC from human respiratory sounds

In the last 2 years, medical researchers and clinical scientists have paid close attention to the problem of respiratory sound classification to classify COVID-19 disease symptoms. In the physical world, very few AI-based (Artificial Intelligence) techniques are often used to detect COVID-19/SARS-CoV-2 respiratory disease symptoms from the human respiratory system-generated acoustic sounds such as acoustic voice sound, breathing (inhale and exhale) sounds, and cough sound. We propose a light-weight Convolutional Neural Network (CNN) with Modified-Mel-frequency Cepstral Coefficient (M-MFCC) using different depths and kernel sizes to classify COVID-19 and other respiratory sound disease symptoms such as Asthma, Pertussis, and Bronchitis. The proposed network outperforms conventional feature extraction models and existing Deep Learning (DL) models for COVID-19/SARS-CoV-2 classification accuracy in the range of 4-10%. The model's performance is compared with the COVID-19 crowdsourced benchmark dataset and gives a competitive performance. We applied different receptive fields and depths in the proposed model to get different contextual information that should aid in classification. And our experiments suggested 1 × 12 receptive fields and a depth of 5-Layer for the light-weight CNN to extract and identify the features from respiratory sound data. The model is also trained and tested with different modalities of data to showcase its effectiveness in classification.

Using artificial intelligence technology to fight COVID-19: a review

In late December 2019, a new type of coronavirus was discovered, which was later named severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Since its discovery, the virus has spread globally, with 2,975,875 deaths as of 15 April 2021, and has had a huge impact on our health systems and economy. How to suppress the continued spread of new coronary pneumonia is the main task of many scientists and researchers. The introduction of artificial intelligence technology has provided a huge contribution to the suppression of the new coronavirus. This article discusses the main application of artificial intelligence technology in the suppression of coronavirus from three major aspects of identification, prediction, and development through a large amount of literature research, and puts forward the current main challenges and possible development directions. The results show that it is an effective measure to combine artificial intelligence technology with a variety of new technologies to predict and identify COVID-19 patients.

Application of machine learning in the fight against the COVID-19 pandemic: A review

Introduction: Machine learning (ML) plays a significant role in the fight against the COVID-19 (officially known as SARS-CoV-2) pandemic. ML techniques enable the rapid detection of patterns and trends in large datasets. Therefore, ML provides efficient methods to generate knowledge from structured and unstructured data. This potential is particularly significant when the pandemic affects all aspects of human life. It is necessary to collect a large amount of data to identify methods to prevent the spread of infection, early detection, reduction of consequences, and finding appropriate medicine. Modern information and communication technologies (ICT) such as the Internet of Things (IoT) allow the collection of large amounts of data from various sources. Thus, we can create predictive ML-based models for assessments, predictions, and decisions. Methods: This is a review article based on previous studies and scientifically proven knowledge. In this paper, bibliometric data from authoritative databases of research publications (Web of Science, Scopus, PubMed) are combined for bibliometric analyses in the context of ML applications for COVID-19. Aim: This paper reviews some ML-based applications used for mitigating COVID-19. We aimed to identify and review ML potentials and solutions for mitigating the COVID-19 pandemic as well as to present some of the most commonly used ML techniques, algorithms, and datasets applied in the context of COVID-19. Also, we provided some insights into specific emerging ideas and open issues to facilitate future research. Conclusion: ML is an effective tool for diagnosing and early detection of symptoms, predicting the spread of a pandemic, developing medicines and vaccines, etc.

External validation of Machine Learning models for COVID-19 detection based on Complete Blood Count

PURPOSE

The rRT-PCR for COVID-19 diagnosis is affected by long turnaround time, potential shortage of reagents, high false-negative rates and high costs. Routine hematochemical tests are a faster and less expensive alternative for diagnosis. Thus, Machine Learning (ML) has been applied to hematological parameters to develop diagnostic tools and help clinicians in promptly managing positive patients. However, few ML models have been externally validated, making their real-world applicability unclear.

METHODS

We externally validate 6 state-of-the-art diagnostic ML models, based on Complete Blood Count (CBC) and trained on a dataset encompassing 816 COVID-19 positive cases. The external validation was performed based on two datasets, collected at two different hospitals in northern Italy and encompassing 163 and 104 COVID-19 positive cases, in terms of both error rate and calibration.

RESULTS AND CONCLUSION

We report an average AUC of 95% and average Brier score of 0.11, out-performing existing ML methods, and showing good cross-site transportability. The best performing model (SVM) reported an average AUC of 97.5% (Sensitivity: 87.5%, Specificity: 94%), comparable with the performance of RT-PCR, and was also the best calibrated. The validated models can be useful in the early identification of potential COVID-19 patients, due to the rapid availability of CBC exams, and in multiple test settings.

Reflections on epistemological aspects of artificial intelligence during the COVID-19 pandemic

Artificial intelligence plays an important role and has been used by several countries as a health strategy in an attempt to understand, control and find a cure for the disease caused by Coronavirus. These intelligent systems can assist in accelerating the process of developing antivirals for Coronavirus and in predicting new variants of this virus. For this reason, much research on COVID-19 has been developed with the aim of contributing to new discoveries about the Coronavirus. However, there are some epistemological aspects about the use of AI in this pandemic period of Covid-19 that deserve to be discussed and need reflections. In this scenario, this article presents a reflection on the two epistemological aspects faced by the COVID-19 pandemic: (1) The epistemological aspect resulting from the use of patient data to fill the knowledge base of intelligent systems; (2) the epistemological problem arising from the dependence of health professionals on the results/diagnoses issued by intelligent systems. In addition, we present some epistemological challenges to be implemented in a pandemic period.

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example

Drug repurposing is an invaluable strategy to identify new uses for existing drug therapies that overcome many of the time and financial costs associated with novel drug development. The COVID-19 pandemic has driven an unprecedented surge in the development and use of bioinformatic tools to identify candidate repurposable drugs. Using COVID-19 as a case study, we discuss examples of machine-learning and signature-based approaches that have been adapted to rapidly identify candidate drugs. The Library of Integrated Network-based Signatures (LINCS) and Connectivity Map (CMap) are commonly used repositories and have the advantage of being amenable to use by scientists with limited bioinformatic training. Next, we discuss how these recent advances in bioinformatic drug repurposing approaches might be adapted to identify repurposable drugs for CNS disorders. As the development of novel therapies that successfully target the cause of neuropsychiatric and neurological disorders has stalled, there is a pressing need for innovative strategies to treat these complex brain disorders. Bioinformatic approaches to identify repurposable drugs provide an exciting avenue of research that offer promise for improved treatments for CNS disorders.

Differential evolution and particle swarm optimization against COVID-19

COVID-19 disease, which highly affected global life in 2020, led to a rapid scientific response. Versatile optimization methods found their application in scientific studies related to COVID-19 pandemic. Differential Evolution (DE) and Particle Swarm Optimization (PSO) are two metaheuristics that for over two decades have been widely researched and used in various fields of science. In this paper a survey of DE and PSO applications for problems related with COVID-19 pandemic that were rapidly published in 2020 is presented from two different points of view: 1. practitioners seeking the appropriate method to solve particular problem, 2. experts in metaheuristics that are interested in methodological details, inter comparisons between different methods, and the ways for improvement. The effectiveness and popularity of DE and PSO is analyzed in the context of other metaheuristics used against COVID-19. It is found that in COVID-19 related studies: 1. DE and PSO are most frequently used for calibration of epidemiological models and image-based classification of patients or symptoms, but applications are versatile, even interconnecting the pandemic and humanities; 2. reporting on DE or PSO methodological details is often scarce, and the choices made are not necessarily appropriate for the particular algorithm or problem; 3. mainly the basic variants of DE and PSO that were proposed in the late XX century are applied, and research performed in recent two decades is rather ignored; 4. the number of citations and the availability of codes in various programming languages seems to be the main factors for choosing metaheuristics that are finally used.

Deep forest model for diagnosing COVID-19 from routine blood tests

The Coronavirus Disease 2019 (COVID-19) global pandemic has threatened the lives of people worldwide and posed considerable challenges. Early and accurate screening of infected people is vital for combating the disease. To help with the limited quantity of swab tests, we propose a machine learning prediction model to accurately diagnose COVID-19 from clinical and/or routine laboratory data. The model exploits a new ensemble-based method called the deep forest (DF), where multiple classifiers in multiple layers are used to encourage diversity and improve performance. The cascade level employs the layer-by-layer processing and is constructed from three different classifiers: extra trees, XGBoost, and LightGBM. The prediction model was trained and evaluated on two publicly available datasets. Experimental results show that the proposed DF model has an accuracy of 99.5%, sensitivity of 95.28%, and specificity of 99.96%. These performance metrics are comparable to other well-established machine learning techniques, and hence DF model can serve as a fast screening tool for COVID-19 patients at places where testing is scarce.

Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study

INTRODUCTION

Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease surveillance. In this protocol, we evaluate the ability of population-based digital cough surveillance to predict the incidence of respiratory diseases at population level in Navarra, Spain, while assessing individual determinants of uptake of these platforms.

METHODS AND ANALYSIS

Participants in the Cendea de Cizur, Zizur Mayor or attending the local University of Navarra (Pamplona) will be invited to monitor their night-time cough using the smartphone app Hyfe Cough Tracker. Detected coughs will be aggregated in time and space. Incidence of COVID-19 and other diagnosed respiratory diseases within the participants cohort, and the study area and population will be collected from local health facilities and used to carry out an autoregressive moving average analysis on those independent time series. In a mixed-methods design, we will explore barriers and facilitators of continuous digital cough monitoring by evaluating participation patterns and sociodemographic characteristics. Participants will fill an acceptability questionnaire and a subgroup will participate in focus group discussions.

ETHICS AND DISSEMINATION

Ethics approval was obtained from the ethics committee of the Centre Hospitalier de l'Université de Montréal, Canada and the Medical Research Ethics Committee of Navarre, Spain. Preliminary findings will be shared with civil and health authorities and reported to individual participants. Results will be submitted for publication in peer-reviewed scientific journals and international conferences.

TRIAL REGISTRATION NUMBER

NCT04762693.

COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review

The recent COVID-19 pandemic, which broke at the end of the year 2019 in Wuhan, China, has infected more than 98.52 million people by today (January 23, 2021) with over 2.11 million deaths across the globe. To combat the growing pandemic on urgent basis, there is need to design effective solutions using new techniques that could exploit recent technology, such as machine learning, deep learning, big data, artificial intelligence, Internet of Things, for identification and tracking of COVID-19 cases in near real time. These technologies have offered inexpensive and rapid solution for proper screening, analyzing, prediction and tracking of COVID-19 positive cases. In this paper, a detailed review of the role of AI as a decisive tool for prognosis, analyze, and tracking the COVID-19 cases is performed. We searched various databases including Google Scholar, IEEE Library, Scopus and Web of Science using a combination of different keywords consisting of COVID-19 and AI. We have identified various applications, where AI can help healthcare practitioners in the process of identification and monitoring of COVID-19 cases. A compact summary of the corona virus cases are first highlighted, followed by the application of AI. Finally, we conclude the paper by highlighting new research directions and discuss the research challenges. Even though scientists and researchers have gathered and exchanged sufficient knowledge over last couple of months, but this structured review also examined technological perspectives while encompassing the medical aspect to help the healthcare practitioners, policymakers, decision makers, policymakers, AI scientists and virologists to quell this infectious COVID-19 pandemic outbreak.

Overview of current state of research on the application of artificial intelligence techniques for COVID-19

BACKGROUND

Until now, there are still a limited number of resources available to predict and diagnose COVID-19 disease. The design of novel drug-drug interaction for COVID-19 patients is an open area of research. Also, the development of the COVID-19 rapid testing kits is still a challenging task.

METHODOLOGY

This review focuses on two prime challenges caused by urgent needs to effectively address the challenges of the COVID-19 pandemic, i.e., the development of COVID-19 classification tools and drug discovery models for COVID-19 infected patients with the help of artificial intelligence (AI) based techniques such as machine learning and deep learning models.

RESULTS

In this paper, various AI-based techniques are studied and evaluated by the means of applying these techniques for the prediction and diagnosis of COVID-19 disease. This study provides recommendations for future research and facilitates knowledge collection and formation on the application of the AI techniques for dealing with the COVID-19 epidemic and its consequences.

CONCLUSIONS

The AI techniques can be an effective tool to tackle the epidemic caused by COVID-19. These may be utilized in four main fields such as prediction, diagnosis, drug design, and analyzing social implications for COVID-19 infected patients.

A Comparative NLP-Based Study on the Current Trends and Future Directions in COVID-19 Research

COVID-19 is a global health crisis that has altered human life and still promises to create ripples of death and destruction in its wake. The sea of scientific literature published over a short time-span to understand and mitigate this global phenomenon necessitates concerted efforts to organize our findings and focus on the unexplored facets of the disease. In this work, we applied natural language processing (NLP) based approaches on scientific literature published on COVID-19 to infer significant keywords that have contributed to our social, economic, demographic, psychological, epidemiological, clinical, and medical understanding of this pandemic. We identify key terms appearing in COVID literature that vary in representation when compared to other virus-borne diseases such as MERS, Ebola, and Influenza. We also identify countries, topics, and research articles that demonstrate that the scientific community is still reacting to the short-term threats such as transmissibility, health risks, treatment plans, and public policies, underpinning the need for collective international efforts towards long-term immunization and drug-related challenges. Furthermore, our study highlights several long-term research directions that are urgently needed for COVID-19 such as: global collaboration to create international open-access data repositories, policymaking to curb future outbreaks, psychological repercussions of COVID-19, vaccine development for SARS-CoV-2 variants and their long-term efficacy studies, and mental health issues in both children and elderly.

The Promise of AI in Detection, Diagnosis, and Epidemiology for Combating COVID-19: Beyond the Hype

COVID-19 has created enormous suffering, affecting lives, and causing deaths. The ease with which this type of coronavirus can spread has exposed weaknesses of many healthcare systems around the world. Since its emergence, many governments, research communities, commercial enterprises, and other institutions and stakeholders around the world have been fighting in various ways to curb the spread of the disease. Science and technology have helped in the implementation of policies of many governments that are directed toward mitigating the impacts of the pandemic and in diagnosing and providing care for the disease. Recent technological tools, artificial intelligence (AI) tools in particular, have also been explored to track the spread of the coronavirus, identify patients with high mortality risk and diagnose patients for the disease. In this paper, areas where AI techniques are being used in the detection, diagnosis and epidemiological predictions, forecasting and social control for combating COVID-19 are discussed, highlighting areas of successful applications and underscoring issues that need to be addressed to achieve significant progress in battling COVID-19 and future pandemics. Several AI systems have been developed for diagnosing COVID-19 using medical imaging modalities such as chest CT and X-ray images. These AI systems mainly differ in their choices of the algorithms for image segmentation, classification and disease diagnosis. Other AI-based systems have focused on predicting mortality rate, long-term patient hospitalization and patient outcomes for COVID-19. AI has huge potential in the battle against the COVID-19 pandemic but successful practical deployments of these AI-based tools have so far been limited due to challenges such as limited data accessibility, the need for external evaluation of AI models, the lack of awareness of AI experts of the regulatory landscape governing the deployment of AI tools in healthcare, the need for clinicians and other experts to work with AI experts in a multidisciplinary context and the need to address public concerns over data collection, privacy, and protection. Having a dedicated team with expertise in medical data collection, privacy, access and sharing, using federated learning whereby AI scientists hand over training algorithms to the healthcare institutions to train models locally, and taking full advantage of biomedical data stored in biobanks can alleviate some of problems posed by these challenges. Addressing these challenges will ultimately accelerate the translation of AI research into practical and useful solutions for combating pandemics.

A hybrid data envelopment analysis-artificial neural network prediction model for COVID-19 severity in transplant recipients

In an overwhelming demand scenario, such as the SARS-CoV-2 pandemic, pressure over health systems may outburst their predicted capacity to deal with such extreme situations. Therefore, in order to successfully face a health emergency, scientific evidence and validated models are needed to provide real-time information that could be applied by any health center, especially for high-risk populations, such as transplant recipients. We have developed a hybrid prediction model whose accuracy relative to several alternative configurations has been validated through a battery of clustering techniques. Using hospital admission data from a cohort of hospitalized transplant patients, our hybrid Data Envelopment Analysis (DEA)—Artificial Neural Network (ANN) model extrapolates the progression towards severe COVID-19 disease with an accuracy of 96.3%, outperforming any competing model, such as logistic regression (65.5%) and random forest (44.8%). In this regard, DEA-ANN allows us to categorize the evolution of patients through the values of the analyses performed at hospital admission. Our prediction model may help guiding COVID-19 management through the identification of key predictors that permit a sustainable management of resources in a patient-centered model.

Automatic COVID-19 disease diagnosis using 1D convolutional neural network and augmentation with human respiratory sound based on parameters: cough, breath, and voice

The issue in respiratory sound classification has attained good attention from the clinical scientists and medical researcher's group in the last year to diagnosing COVID-19 disease. To date, various models of Artificial Intelligence (AI) entered into the real-world to detect the COVID-19 disease from human-generated sounds such as voice/speech, cough, and breath. The Convolutional Neural Network (CNN) model is implemented for solving a lot of real-world problems on machines based on Artificial Intelligence (AI). In this context, one dimension (1D) CNN is suggested and implemented to diagnose respiratory diseases of COVID-19 from human respiratory sounds such as a voice, cough, and breath. An augmentation-based mechanism is applied to improve the preprocessing performance of the COVID-19 sounds dataset and to automate COVID-19 disease diagnosis using the 1D convolutional network. Furthermore, a DDAE (Data De-noising Auto Encoder) technique is used to generate deep sound features such as the input function to the 1D CNN instead of adopting the standard input of MFCC (Mel-frequency cepstral coefficient), and it is performed better accuracy and performance than previous models.

RESULTS

As a result, around 4% accuracy is achieved than traditional MFCC. We have classified COVID-19 sounds, asthma sounds, and regular healthy sounds using a 1D CNN classifier and shown around 90% accuracy to detect the COVID-19 disease from respiratory sounds.

CONCLUSION

A Data De-noising Auto Encoder (DDAE) was adopted to extract the acoustic sound signals in-depth features instead of traditional MFCC. The proposed model improves efficiently to classify COVID-19 sounds for detecting COVID-19 positive symptoms.

COVID-19: advance in laboratory diagnostic strategy and technology

SARS-CoV-2 is one of the beta-coronaviruses with the spike protein. It invades host cells by binding to angiotensin converting enzyme 2 (ACE2). This newly discovered virus can result in excessive inflammation and immune pathological damage, as shown by a decreased number of peripheral lymphocytes, increased levels of cytokines, and damages of lung, heart, liver, kidney, and other organs. Effective therapeutic modalities such as new antiviral drugs and vaccines against this emerging virus need to be thoroughly studied and developed. However, so far the only recognized but mild progress in this area is the screening of old drugs for new uses. Therefore, rapid and accurate laboratory SARS-CoV-2 testing approaches are the important basis of identification and blockage of COVID-19 transmission. For COVID-19 patients with different clinical classifications (mild, common, severe, and critically severe), dynamic monitoring of functional indicators of susceptible and vital organs is an important strategy for evaluating therapeutic efficacy and prognosis. In this review, we summarized SARS-CoV-2 laboratory diagnostic schemes, pathophysiological indices of tissues and organs of COVID-19 patients, and laboratory diagnostic strategies for distinct disease stages. Further, we discussed the importance of hierarchical management and dynamic observation in SARS-CoV-2 laboratory diagnostics. We then summed up the advance in SARS-CoV-2 testing technology and described the prospect of intelligent medicine in the prevention of infectious disease outbreaks.

SOM-LWL method for identification of COVID-19 on chest X-rays

The outbreak of coronavirus disease 2019 (COVID-19) has had an immense impact on world health and daily life in many countries. Sturdy observing of the initial site of infection in patients is crucial to gain control in the struggle with COVID-19. The early automated detection of the recent coronavirus disease (COVID-19) will help to limit its dissemination worldwide. Many initial studies have focused on the identification of the genetic material of coronavirus and have a poor detection rate for long-term surgery. The first imaging procedure that played an important role in COVID-19 treatment was the chest X-ray. Radiological imaging is often used as a method that emphasizes the performance of chest X-rays. Recent findings indicate the presence of COVID-19 in patients with irregular findings on chest X-rays. There are many reports on this topic that include machine learning strategies for the identification of COVID-19 using chest X-rays. Other current studies have used non-public datasets and complex artificial intelligence (AI) systems. In our research, we suggested a new COVID-19 identification technique based on the locality-weighted learning and self-organization map (LWL-SOM) strategy for detecting and capturing COVID-19 cases. We first grouped images from chest X-ray datasets based on their similar features in different clusters using the SOM strategy in order to discriminate between the COVID-19 and non-COVID-19 cases. Then, we built our intelligent learning model based on the LWL algorithm to diagnose and detect COVID-19 cases. The proposed SOM-LWL model improved the correlation coefficient performance results between the Covid19, no-finding, and pneumonia cases; pneumonia and no-finding cases; Covid19 and pneumonia cases; and Covid19 and no-finding cases from 0.9613 to 0.9788, 0.6113 to 1 0.8783 to 0.9999, and 0.8894 to 1, respectively. The proposed LWL-SOM had better results for discriminating COVID-19 and non-COVID-19 patients than the current machine learning-based solutions using AI evaluation measures.

Automatic COVID-19 disease diagnosis using 1D convolutional neural network and augmentation with human respiratory sound based on parameters: cough, breath, and voice

The issue in respiratory sound classification has attained good attention from the clinical scientists and medical researcher's group in the last year to diagnosing COVID-19 disease. To date, various models of Artificial Intelligence (AI) entered into the real-world to detect the COVID-19 disease from human-generated sounds such as voice/speech, cough, and breath. The Convolutional Neural Network (CNN) model is implemented for solving a lot of real-world problems on machines based on Artificial Intelligence (AI). In this context, one dimension (1D) CNN is suggested and implemented to diagnose respiratory diseases of COVID-19 from human respiratory sounds such as a voice, cough, and breath. An augmentation-based mechanism is applied to improve the preprocessing performance of the COVID-19 sounds dataset and to automate COVID-19 disease diagnosis using the 1D convolutional network. Furthermore, a DDAE (Data De-noising Auto Encoder) technique is used to generate deep sound features such as the input function to the 1D CNN instead of adopting the standard input of MFCC (Mel-frequency cepstral coefficient), and it is performed better accuracy and performance than previous models.

RESULTS

As a result, around 4% accuracy is achieved than traditional MFCC. We have classified COVID-19 sounds, asthma sounds, and regular healthy sounds using a 1D CNN classifier and shown around 90% accuracy to detect the COVID-19 disease from respiratory sounds.

CONCLUSION

A Data De-noising Auto Encoder (DDAE) was adopted to extract the acoustic sound signals in-depth features instead of traditional MFCC. The proposed model improves efficiently to classify COVID-19 sounds for detecting COVID-19 positive symptoms.